Doris Riether

618 citations

24 papers · 419 indexed · h-index 13

Impact in

Pharmacology top 10%
- Cannabis and Cannabinoid Research
Toxicology top 10%

Papers in ⓘ

Molecular Biology 13
- Pharmacological Receptor Mechanisms and Effects 5
- Advanced biosensing and bioanalysis techniques 2
- Receptor Mechanisms and Signaling 2
Pharmacology 9
- Cannabis and Cannabinoid Research 8

Co-authors: Johann Mulzer (3 shared papers)Mary Ann Gawinowicz (1 shared paper)Dalibor Sameš (1 shared paper)Gong Chen (1 shared paper)David Thomson (13 shared papers)Mark J. Gemkow (7 shared papers)Renée Zindell (6 shared papers)Christian Harcken (6 shared papers)
Journals: Bioorganic & Medicinal Chemistry Letters (10 papers)Organic Letters (2 papers)Journal of Medicinal Chemistry (2 papers)European Journal of Organic Chemistry (1 paper)Journal of the American Chemical Society (1 paper)
Partner nations: United States Germany United Kingdom

In The Last Decade

Doris Riether

24 papers receiving 410 citations

Peers

Countries citing papers authored by Doris Riether

Since Specialization

Citations

This map shows the geographic impact of Doris Riether's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doris Riether with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doris Riether more than expected).

Fields of papers citing papers by Doris Riether

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Doris Riether. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doris Riether. The network helps show where Doris Riether may publish in the future.

Co-authors

The 25 scholars most cited alongside Doris Riether, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Doris Riether Line = papers co-authored together Doris Riether links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Reactivity of Functional Groups on the Protein Surface: Development of Epoxide Probes for Protein Labeling Journal of the American Chemical Society ·Gong Chen, A. Heim, Doris Riether, Dominic J. Yee, Yelena Milgrom, Mary Ann Gawinowicz, Dalibor Sameš	2003	107
2	Nonsteroidal Dissociated Glucocorticoid Agonists Containing Azaindoles as Steroid A-Ring Mimetics Journal of Medicinal Chemistry ·Doris Riether, Christian Harcken, Hossein Razavi, Daniel Kuzmich, Thomas D. Gilmore, Jörg Bentzien, Edward J. Pack, Donald Souza, Richard M. Nelson, Alison Kukulka, Tazmeen N. Fadra, Ljiljana Žuvela-Jelaska, Josephine Pelletier, Roger Dinallo, Mark Panzenbeck, Carol Torcellini, Gerald Nabozny, David Thomson	2010	36
3	Selective cannabinoid receptor 2 modulators: a patent review 2009 – present Expert Opinion on Therapeutic Patents ·Doris Riether	2012	30
4	Arylsulfonamide CB2 receptor agonists: SAR and optimization of CB2 selectivity Bioorganic & Medicinal Chemistry Letters ·Monika Ermann, Doris Riether, Edward R. Walker, Innocent Mushi, James E. Jenkins, Beatriz Noya-Marino, Mark L. Brewer, Malcolm G. Taylor, Patricia Amouzegh, Stephen P. East, Brian Dymock, Mark J. Gemkow, Andreas F. Kahrs, Andreas Ebneth, Sabine Löbbe, Kathy O’Shea, Daw-Tsun Shih, David Thomson	2008	27
5	Identification of Highly Efficacious Glucocorticoid Receptor Agonists with a Potential for Reduced Clinical Bone Side Effects Journal of Medicinal Chemistry ·Christian Harcken, Doris Riether, Daniel Kuzmich, Pingrong Liu, Raj Betageri, Mark Ralph, Michel J. Emmanuel, Jonathan T. Reeves, Angela Berry, Donald Souza, Richard M. Nelson, Alison Kukulka, Tazmeen N. Fadra, Ljiljana Žuvela-Jelaska, Roger Dinallo, Jörg Bentzien, Gerald Nabozny, David Thomson	2014	24
6	Total Synthesis of Cobyric Acid: Historical Development and Recent Synthetic Innovations European Journal of Organic Chemistry ·Doris Riether, Johann Mulzer	2002	23
7	Selective CB2 receptor agonists. Part 1: The identification of novel ligands through computer-aided drug design (CADD) approaches Bioorganic & Medicinal Chemistry Letters ·Eugene R. Hickey, Renée Zindell, Pier F. Cirillo, Lifen Wu, Monika Ermann, Angela Berry, David Thomson, Claudia Albrecht, Mark J. Gemkow, Doris Riether	2014	19
8	Morpholine containing CB2 selective agonists Bioorganic & Medicinal Chemistry Letters ·Renée Zindell, Doris Riether, Todd Bosanac, Angela Berry, Mark J. Gemkow, Andreas Ebneth, Sabine Löbbe, Ernest Raymond, Diane Thome, Daw-Tsun Shih, David Thomson	2009	16
9	Efficient Synthesis of the D-Ring Fragment of Cobyric Acid Organic Letters ·Johann Mulzer, Doris Riether	2000	16
10	Optimization of Drug-Like Properties of Nonsteroidal Glucocorticoid Mimetics and Identification of a Clinical Candidate ACS Medicinal Chemistry Letters ·Christian Harcken, Doris Riether, Pingrong Liu, Hossein Razavi, Usha Patel, Thomas Lee, Todd Bosanac, Yancey D. Ward, Mark Ralph, Zhidong Chen, Donald Souza, Richard M. Nelson, Alison Kukulka, Tazmeen Fadra-Khan, Ljiljana Žuvela-Jelaska, Mita Patel, David Thomson, Gerald Nabozny	2014	16
11	1,4-Diazepane compounds as potent and selective CB2 agonists: Optimization of metabolic stability Bioorganic & Medicinal Chemistry Letters ·Doris Riether, Lifen Wu, Pier F. Cirillo, Angela Berry, Edward R. Walker, Monika Ermann, Beatriz Noya-Marino, James E. Jenkins, Dan Albaugh, Claudia Albrecht, Michael T. Fisher, Mark J. Gemkow, Heather Grbic, Sabine Löbbe, Clemens Möller, Kathy O’Shea, Achim Sauer, Daw-Tsun Shih, David Thomson	2011	13
12	Selective CB2 receptor agonists. Part 2: Structure–activity relationship studies and optimization of proline-based compounds Bioorganic & Medicinal Chemistry Letters ·Doris Riether, Renée Zindell, Lifen Wu, Raj Betageri, James E. Jenkins, Someina Khor, Angela Berry, Eugene R. Hickey, Monika Ermann, Claudia Albrecht, Angelo Ceci, Mark J. Gemkow, N. Nagaraja, Helmut Romig, Achim Sauer, David Thomson	2014	13
13	Synthesis of the C-ring fragment of cobyric acid Tetrahedron Letters ·Johann Mulzer, Doris Riether	1999	13
14	Selective CB2 receptor agonists. Part 3: The optimization of a piperidine-based series that demonstrated efficacy in an in vivo neuropathic pain model Bioorganic & Medicinal Chemistry Letters ·Alessandra Bartolozzi, Pier F. Cirillo, Angela Berry, Eugene R. Hickey, David Thomson, Lifen Wu, Renée Zindell, Claudia Albrecht, Angelo Ceci, Mark J. Gemkow, N. Nagaraja, Helmut Romig, Achim Sauer, Doris Riether	2014	12
15	Epigenetic Modification 6‐Methyladenosine Can Impact the Potency and Specificity of siRNA ChemBioChem ·Anna M. Rydzik, Dirk Gottschling, Eric J. Simon, Wioletta Skrońska-Wąsek, Jörg F. Rippmann, Doris Riether	2020	10
16	Electrochemical Synthesis and Structure Analysis of Neocoenzyme B12 - An Epimer of Coenzyme B12 with a Remarkably Flexible Organometallic Group Helvetica Chimica Acta ·Georg Kontaxis, Doris Riether, Renate B. Hannak, Martin Tollinger, Bernhard Kräutler	1999	10
17	Aryl 1,4-diazepane compounds as potent and selective CB2 agonists: Optimization of drug-like properties and target independent parameters Bioorganic & Medicinal Chemistry Letters ·Renée Zindell, Edward R. Walker, John Scott, Patricia Amouzegh, Lifen Wu, Monika Ermann, David Thomson, Micheal B. Fisher, Cody L. Fullenwider, Heather Grbic, Paul V. Kaplita, Brian Linehan, Mita Patel, Monica Patel, Sabine Löbbe, Svenja Block, Claudia Albrecht, Mark J. Gemkow, Daw-Tsun Shih, Doris Riether	2011	9
18	Discovery of a potent and dissociated non-steroidal glucocorticoid receptor agonist containing an alkyl carbinol pharmacophore Bioorganic & Medicinal Chemistry Letters ·Hossein Razavi, Doris Riether, Christian Harcken, Jörg Bentzien, Roger Dinallo, Donald Souza, Richard M. Nelson, Alison Kukulka, Tazmeen Fadra-Khan, Edward J. Pack, Ljiljana Žuvela-Jelaska, Josephine Pelletier, Mark Panzenbeck, Carol Torcellini, John Proudfoot, Gerald Nabozny, David Thomson	2014	7
19	Discovery and optimization of oxadiazole-based FLAP inhibitors Bioorganic & Medicinal Chemistry Letters ·Alessandra Bartolozzi, Asitha Abeywardane, Todd Bosanac, John A. Broadwater, Zhidong Chen, J. Matthew Hutzler, John D. Huber, Peter Nemoto, Alan Olague, Doris Riether, T. R. Simpson, Hidenori Takahashi, Lifen Wu, Yunlong Zhang, Renée Zindell	2017	4
20	Synthesis of 2′-modified N6-methyladenosine phosphoramidites and their incorporation into siRNA Bioorganic & Medicinal Chemistry Letters ·Anna M. Rydzik, Doris Riether, Dirk Gottschling	2023	3

About Doris Riether

Doris Riether is a scholar working on Molecular Biology, Pharmacology, Organic Chemistry, Cellular and Molecular Neuroscience and Toxicology, having authored 24 papers that have together received 419 indexed citations. Recurring topics across this work include Cannabis and Cannabinoid Research (8 papers), Neurotransmitter Receptor Influence on Behavior (5 papers), Pharmacological Receptor Mechanisms and Effects (5 papers), Forensic Toxicology and Drug Analysis (3 papers), Estrogen and related hormone effects (3 papers), Advanced biosensing and bioanalysis techniques (2 papers), Synthesis and Biological Evaluation (2 papers) and Receptor Mechanisms and Signaling (2 papers). The work is most often cited by research in Pharmacology (127 citations), Toxicology (21 citations), Organic Chemistry (153 citations), Cellular and Molecular Neuroscience (80 citations) and Pharmaceutical Science (26 citations). Doris Riether has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Johann Mulzer, Mary Ann Gawinowicz, Dalibor Sameš, Gong Chen, David Thomson, Mark J. Gemkow, Renée Zindell, Christian Harcken, Monika Ermann and Gerald Nabozny. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Organic Letters, Journal of Medicinal Chemistry, European Journal of Organic Chemistry and Journal of the American Chemical Society.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact